The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Baculovirus Expression System Market Research Report 2025

Global Baculovirus Expression System Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1803681

No of Pages : 100

Synopsis
Baculovirus Expression System is a type of protein expression system that uses insect cells and baculoviruses to produce recombinant proteins. This system has become increasingly popular for the expression of eukaryotic proteins that are difficult to produce in other systems, such as bacteria or yeast. Baculovirus Expression System involves the insertion of a gene of interest into a baculovirus genome, which is then used to infect insect cells. The infected cells then produce large quantities of the recombinant protein, which can be purified and used for various applications, such as drug discovery, vaccine development, and protein structure analysis.
Global Baculovirus Expression System market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Baculovirus Expression System market research.
The global market for Baculovirus Expression System has been witnessing steady growth due to its versatility, high expression levels, and post-translational modifications that closely resemble those in higher eukaryotes. The system finds applications in various fields, including biopharmaceuticals, research, and industrial biotechnology. The United States and Canada have a strong presence in the Baculovirus Expression System market, driven by a robust biopharmaceutical industry and significant investments in research and development. European countries have a prominent role in academic research and industrial applications of the Baculovirus Expression System, with a focus on producing high-value recombinant proteins. Asia-Pacific is experiencing growth in the Baculovirus Expression System market, driven by increasing research activities, biopharmaceutical development, and the expansion of the industrial biotechnology sector. The Baculovirus Expression System market is expected to continue growing as biopharmaceutical companies seek efficient and reliable methods for producing complex proteins. Advances in gene editing technologies and the development of high-yield insect cell lines are likely to further enhance the capabilities of the system. Additionally, the increasing demand for biologics and personalized medicine is expected to drive the adoption of Baculovirus Expression System in the coming years.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Baculovirus Expression System market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Thermo Fisher Scientific
Bio Basic
GenScript Biotech
Oxford Expression Technologies
ProteoGenix
Promab Biotechnologies
MTIBIO
AMSBIO
Kemp Proteins
Takara Bio
Genosphere Biotechnologies
Biocompare
Expression Systems
Creative BioMart
Profacgen
Sino Biological
Hangzhou Clongene Biotech
Segment by Type
Autographa Californica Multiple Nucleopolyhedrovirus
Bombyx Mori Nucleopolyhedrovirus
Others
Segment by Application
Drugs Development
Biomedical Research
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Baculovirus Expression System report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Baculovirus Expression System Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Autographa Californica Multiple Nucleopolyhedrovirus
1.2.3 Bombyx Mori Nucleopolyhedrovirus
1.2.4 Others
1.3 Market by Application
1.3.1 Global Baculovirus Expression System Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Drugs Development
1.3.3 Biomedical Research
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Baculovirus Expression System Market Perspective (2018-2029)
2.2 Baculovirus Expression System Growth Trends by Region
2.2.1 Global Baculovirus Expression System Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Baculovirus Expression System Historic Market Size by Region (2018-2023)
2.2.3 Baculovirus Expression System Forecasted Market Size by Region (2024-2029)
2.3 Baculovirus Expression System Market Dynamics
2.3.1 Baculovirus Expression System Industry Trends
2.3.2 Baculovirus Expression System Market Drivers
2.3.3 Baculovirus Expression System Market Challenges
2.3.4 Baculovirus Expression System Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Baculovirus Expression System Players by Revenue
3.1.1 Global Top Baculovirus Expression System Players by Revenue (2018-2023)
3.1.2 Global Baculovirus Expression System Revenue Market Share by Players (2018-2023)
3.2 Global Baculovirus Expression System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Baculovirus Expression System Revenue
3.4 Global Baculovirus Expression System Market Concentration Ratio
3.4.1 Global Baculovirus Expression System Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Baculovirus Expression System Revenue in 2022
3.5 Baculovirus Expression System Key Players Head office and Area Served
3.6 Key Players Baculovirus Expression System Product Solution and Service
3.7 Date of Enter into Baculovirus Expression System Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Baculovirus Expression System Breakdown Data by Type
4.1 Global Baculovirus Expression System Historic Market Size by Type (2018-2023)
4.2 Global Baculovirus Expression System Forecasted Market Size by Type (2024-2029)
5 Baculovirus Expression System Breakdown Data by Application
5.1 Global Baculovirus Expression System Historic Market Size by Application (2018-2023)
5.2 Global Baculovirus Expression System Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Baculovirus Expression System Market Size (2018-2029)
6.2 North America Baculovirus Expression System Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Baculovirus Expression System Market Size by Country (2018-2023)
6.4 North America Baculovirus Expression System Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Baculovirus Expression System Market Size (2018-2029)
7.2 Europe Baculovirus Expression System Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Baculovirus Expression System Market Size by Country (2018-2023)
7.4 Europe Baculovirus Expression System Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Baculovirus Expression System Market Size (2018-2029)
8.2 Asia-Pacific Baculovirus Expression System Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Baculovirus Expression System Market Size by Region (2018-2023)
8.4 Asia-Pacific Baculovirus Expression System Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Baculovirus Expression System Market Size (2018-2029)
9.2 Latin America Baculovirus Expression System Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Baculovirus Expression System Market Size by Country (2018-2023)
9.4 Latin America Baculovirus Expression System Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Baculovirus Expression System Market Size (2018-2029)
10.2 Middle East & Africa Baculovirus Expression System Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Baculovirus Expression System Market Size by Country (2018-2023)
10.4 Middle East & Africa Baculovirus Expression System Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Baculovirus Expression System Introduction
11.1.4 Thermo Fisher Scientific Revenue in Baculovirus Expression System Business (2018-2023)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Bio Basic
11.2.1 Bio Basic Company Detail
11.2.2 Bio Basic Business Overview
11.2.3 Bio Basic Baculovirus Expression System Introduction
11.2.4 Bio Basic Revenue in Baculovirus Expression System Business (2018-2023)
11.2.5 Bio Basic Recent Development
11.3 GenScript Biotech
11.3.1 GenScript Biotech Company Detail
11.3.2 GenScript Biotech Business Overview
11.3.3 GenScript Biotech Baculovirus Expression System Introduction
11.3.4 GenScript Biotech Revenue in Baculovirus Expression System Business (2018-2023)
11.3.5 GenScript Biotech Recent Development
11.4 Oxford Expression Technologies
11.4.1 Oxford Expression Technologies Company Detail
11.4.2 Oxford Expression Technologies Business Overview
11.4.3 Oxford Expression Technologies Baculovirus Expression System Introduction
11.4.4 Oxford Expression Technologies Revenue in Baculovirus Expression System Business (2018-2023)
11.4.5 Oxford Expression Technologies Recent Development
11.5 ProteoGenix
11.5.1 ProteoGenix Company Detail
11.5.2 ProteoGenix Business Overview
11.5.3 ProteoGenix Baculovirus Expression System Introduction
11.5.4 ProteoGenix Revenue in Baculovirus Expression System Business (2018-2023)
11.5.5 ProteoGenix Recent Development
11.6 Promab Biotechnologies
11.6.1 Promab Biotechnologies Company Detail
11.6.2 Promab Biotechnologies Business Overview
11.6.3 Promab Biotechnologies Baculovirus Expression System Introduction
11.6.4 Promab Biotechnologies Revenue in Baculovirus Expression System Business (2018-2023)
11.6.5 Promab Biotechnologies Recent Development
11.7 MTIBIO
11.7.1 MTIBIO Company Detail
11.7.2 MTIBIO Business Overview
11.7.3 MTIBIO Baculovirus Expression System Introduction
11.7.4 MTIBIO Revenue in Baculovirus Expression System Business (2018-2023)
11.7.5 MTIBIO Recent Development
11.8 AMSBIO
11.8.1 AMSBIO Company Detail
11.8.2 AMSBIO Business Overview
11.8.3 AMSBIO Baculovirus Expression System Introduction
11.8.4 AMSBIO Revenue in Baculovirus Expression System Business (2018-2023)
11.8.5 AMSBIO Recent Development
11.9 Kemp Proteins
11.9.1 Kemp Proteins Company Detail
11.9.2 Kemp Proteins Business Overview
11.9.3 Kemp Proteins Baculovirus Expression System Introduction
11.9.4 Kemp Proteins Revenue in Baculovirus Expression System Business (2018-2023)
11.9.5 Kemp Proteins Recent Development
11.10 Takara Bio
11.10.1 Takara Bio Company Detail
11.10.2 Takara Bio Business Overview
11.10.3 Takara Bio Baculovirus Expression System Introduction
11.10.4 Takara Bio Revenue in Baculovirus Expression System Business (2018-2023)
11.10.5 Takara Bio Recent Development
11.11 Genosphere Biotechnologies
11.11.1 Genosphere Biotechnologies Company Detail
11.11.2 Genosphere Biotechnologies Business Overview
11.11.3 Genosphere Biotechnologies Baculovirus Expression System Introduction
11.11.4 Genosphere Biotechnologies Revenue in Baculovirus Expression System Business (2018-2023)
11.11.5 Genosphere Biotechnologies Recent Development
11.12 Biocompare
11.12.1 Biocompare Company Detail
11.12.2 Biocompare Business Overview
11.12.3 Biocompare Baculovirus Expression System Introduction
11.12.4 Biocompare Revenue in Baculovirus Expression System Business (2018-2023)
11.12.5 Biocompare Recent Development
11.13 Expression Systems
11.13.1 Expression Systems Company Detail
11.13.2 Expression Systems Business Overview
11.13.3 Expression Systems Baculovirus Expression System Introduction
11.13.4 Expression Systems Revenue in Baculovirus Expression System Business (2018-2023)
11.13.5 Expression Systems Recent Development
11.14 Creative BioMart
11.14.1 Creative BioMart Company Detail
11.14.2 Creative BioMart Business Overview
11.14.3 Creative BioMart Baculovirus Expression System Introduction
11.14.4 Creative BioMart Revenue in Baculovirus Expression System Business (2018-2023)
11.14.5 Creative BioMart Recent Development
11.15 Profacgen
11.15.1 Profacgen Company Detail
11.15.2 Profacgen Business Overview
11.15.3 Profacgen Baculovirus Expression System Introduction
11.15.4 Profacgen Revenue in Baculovirus Expression System Business (2018-2023)
11.15.5 Profacgen Recent Development
11.16 Sino Biological
11.16.1 Sino Biological Company Detail
11.16.2 Sino Biological Business Overview
11.16.3 Sino Biological Baculovirus Expression System Introduction
11.16.4 Sino Biological Revenue in Baculovirus Expression System Business (2018-2023)
11.16.5 Sino Biological Recent Development
11.17 Hangzhou Clongene Biotech
11.17.1 Hangzhou Clongene Biotech Company Detail
11.17.2 Hangzhou Clongene Biotech Business Overview
11.17.3 Hangzhou Clongene Biotech Baculovirus Expression System Introduction
11.17.4 Hangzhou Clongene Biotech Revenue in Baculovirus Expression System Business (2018-2023)
11.17.5 Hangzhou Clongene Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’